Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ABCAM Hikes Dividend By 18% As Annual Profit Rises On Higher Revenue

Mon, 10th Sep 2018 09:23

LONDON (Alliance News) - ABCAM PLC on Monday said its profit grew significantly in its recently ended financial year as revenue increased across all of its trading segments.

The life science research tools supplier said pretax profit grew by third in the year to the end of June to GBP69.1 million from GBP51.9 million reported a year earlier, as revenue climbed 7.4% to GBP233.2 million from GBP217.1 million. On a constant currency basis, revenue rose 11%.

The impact of foreign exchange movements in the year was GBP7.1 million unfavourable in revenue, ABCAM said.

On a divisional basis, revenue in Catalogue segment improved 7.1% to GBP216.8 million from GBP202.4 million, while Custom Product & Licensing unit revenue was 12% higher year-on-year at GBP16.4 million compared to GBP14.7 million.

ABCAM raised its annual payout by 18% to 12.00p per share from 10.18p paid the year ago.

Looking forward, the company said it continues to be strongly cash generative and reinvests money in capital projects and in the continued development of its products and services.

"It has been a good year for Abcam, delivering double-digit revenue growth on a constant currency basis and meeting all of our strategic targets," said Chief Executive Alan Hirzel.

The stock was trading 20% lower on Monday at 1,182.00 pence per share.

More News
28 Apr 2014 15:15

DIRECTOR DEALINGS: ABCAM Executive And Wife Sell Shares

LONDON (Alliance News) - ABCAM PLC said Monday that Chief Information Officer Ed Ralph sold 10,000 shares, and his wife Victoria Ralph sold 10,000 shares, all at 390.25 pence each. Following this transaction Ralph has a 0.17% interest in the biotechnology company. Shares in ABCAM were

Read more
28 Apr 2014 14:15

DIRECTOR DEALINGS: Abcam Executives Awarded Shares

LONDON (Alliance News) - Abcam PLC Monday said Scientific Director Mark Bushfield and Commercial Director Philippe Cotrel were awarded matching shares at no cost under the share incentive plan.

Details are as follows.

<

Read more
24 Apr 2014 11:16

DIRECTOR DEALINGS: Abcam Chief Marketing Officer Buys Shares

LONDON (Alliance News) - Abcam PLC said Thursday that Chief Marketing Officer Alan Hirzel purchased 8,000 shares at a price of 387.89 pence per share on Wednesday. Following this transaction, Hirzel's interest in the protein tool supplier is 8,306 shares, representing 0.01% of the company's

Read more
23 Apr 2014 15:31

DIRECTOR DEALINGS: Abcam Non-Executive Buys Shares

LONDON (Alliance News) - Abcam PLC said Wednesday that Non-Executive Director Murray Hennessy purchased 12,800 shares at a price of 389.25 pence per share. The purchase represents Hennessy's only holding in the bio-pharmaceutical company. Abcam shares closed at 385.75 pence per share

Read more
22 Apr 2014 05:12

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
17 Apr 2014 15:19

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
17 Apr 2014 05:16

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
16 Apr 2014 15:15

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
16 Apr 2014 05:10

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
15 Apr 2014 14:39

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
15 Apr 2014 05:12

UK Dividends Calendar - Week Ahead

Read more
14 Apr 2014 15:04

UK Dividends Calendar - Week Ahead

Read more
14 Apr 2014 05:10

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
11 Apr 2014 15:50

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
10 Apr 2014 16:18

Abcam CEO builds family holding

Protein research tool developer Abcam on Thursday said that the wife of its Chief Executive Officer (CEO), Jonathan Milner, purchased 18,000 shares. Roza Gounari spent 373p a share for a total of £67,140. The deal takes Milner's stake in the group to around 13.8% of the issued share capital. J

Read more

Quickpicks are a member only feature

Login to your account